IMCoPharma has recently completed the registrations in Ukraine of the pharmaceutical substance Tamoxifen citrate (API), produced by the company Excella GmbH & Co. KG, Germany. This pharmaceutical substance is used to treat some types of breast cancer in men and women.
In the near future, IMCoPharma is expecting the completion of registration process of other substances such as Temozolomide, Capecitabine, Doxazosin mesylate, Bicalutamide, Trazodone HCl and Ropivacaine HCl produced by company Excella GmbH & Co. KG.
For more information about the products visit our sales portal imcobuy: www.imcobuy.com or contact us.
Tamoxifen citrate - Registration in Ukraine
